Drug Profile
Research programme: diabetes therapeutics - Australian National University/TBG Diagnostics Limited
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Australian National University; Progen Pharmaceuticals Limited
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Type 1 diabetes mellitus
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Type-1 diabetes mellitus in Australia
- 30 Mar 2011 Early research in Type-1 diabetes mellitus in Australia (unspecified route)
- 30 Mar 2011 Pharmacodynamics data from a Early research in Type-1 diabetes mellitus released by Progen Pharmaceuticals